R. Demura et al., INHIBIN ALPHA,BETA(A) SUBUNIT AND ACTIVIN TYPE-II RECEPTOR MESSENGER-RNAS ARE EXPRESSED IN HUMAN BRAIN-TUMORS, Endocrine journal, 42(3), 1995, pp. 307-313
Inhibin and activin were initially isolated as regulators of pituitary
or gonadal hormone and are now known to be growth factors belonging t
o the TGF-beta family with diverse influences on the differentiation a
nd proliferation of various tissues. To investigate the rule of inhibi
n and activin in human brain tumors, the expression of inhibin alpha,
and beta(A) mRNA as well as activin type II receptor (ACTR II) mRNA we
re studied in various human brain tumors. The tumors were divided into
the following 4 groups: 3 Rathke's cleft cysts and 2 craniopharyngiom
as (group 1), 8 meningiomas (group 2), 8 malignant gliomas (group 3),
and various other tumors including 1 each of germinoma, astrocytoma, h
emangioblastoma, and osteochondroma as well as 2 malignant lymphomas a
nd 2 metastatic squamous cell carcinomas (group 4). Immediately after
resection, tumor tissues were homogenized in guanidine thyiocyanate to
extract total RNA. PCR was then performed with reverse-transcribed cD
NA and the respective amplification primers. DNA bands were obtained b
y agarose gel electrophoresis. Messenger RNA for the inhibin beta(A) s
ubunit was demonstrated in all of the tissues studied. In contrast, in
hibin ct subunit mRNA was expressed in 60%, 50%, 75%, and 75% of the t
umors in groups 1, 2, 3 and 4, respectively, whereas ACTR II mRNA was
demonstrated in 20%, 37.5%, 62.5% and 50% of the tumors in each group.
Coexpression of mRNAs for the inhibin alpha, and beta(A) subunits and
ACTR II occurred in some brain tumors. The levels of inhibin alpha an
d ACTR II mRNA tended to be higher in the tumors with a higher grade o
f malignancy. These results indicate that some human brain tumors expr
ess receptors for activin, and that inhibin and activin may play an au
tocrine or paracrine role in brain tumor tissue.